High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer

NCT01198548 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

DRUG: leucovorin calcium
BIOLOGICAL: bevacizumab
DIETARY_SUPPLEMENT: cholecalciferol
DRUG: fluorouracil
DRUG: oxaliplatin
OTHER: pharmacological study

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]